PEBC Part I (MCQ) study materials
PEBC Part I (MCQ) study resources

PEBC Part I (MCQ) study plan

PEBC Part I (MCQ) · Give each week a clear focus.

8 weeks · About 8 hours per week

Week 1

Biomedical sciences (anatomy, physiology, pathophysiology, microbiology, immunology, biochemistry)

  • Build a receptor-level map of the autonomic nervous system: for alpha-1, alpha-2, beta-1, beta-2, M2 and M3, name the organ response, one agonist and one antagonist, and state where each is therapeutically exploited.

  • Trace the cardiac cycle and the RAAS cascade on paper, then compute cardiac output (HR x SV) and mean arterial pressure from three sets of sample vital signs without looking up the formulas.

  • Draw the nephron segment by segment and mark where carbonic-anhydrase inhibitors, loop diuretics, thiazides, potassium-sparing agents and vasopressin antagonists act, together with the electrolyte disturbance each causes.

  • Explain action potential generation and synaptic transmission well enough to predict why local anaesthetics, anticonvulsants and beta-blockers each interrupt excitability at a different step.

  • Assemble a 60-term glossary of laboratory values, abbreviations and pathophysiological terms encountered in cases, and self-quiz until every term is defined from memory.

Your checkpoint

A two-page autonomic and renal drug-target map reproduced from a blank template at 90% or better accuracy, plus a scored 25-question physiology set with a written error log.

Week 2

Biomedical sciences (anatomy, physiology, pathophysiology, microbiology, immunology, biochemistry) & Pharmaceutical sciences (pharmaceutics, pharmacology, medicinal chemistry, pharmacokinetics)

  • Classify bacteria by Gram stain, morphology and oxygen requirement, and pair each major group with three empiric antibiotic options and the resistance mechanism that would defeat them.

  • Contrast innate and adaptive immunity, distinguish the four hypersensitivity types with one drug-induced example each, and explain how live versus inactivated vaccines differ in scheduling and contraindications.

  • Calculate volume of distribution, clearance, half-life and time to steady state for five dosing scenarios, and justify whether each drug follows first-order or zero-order elimination.

  • Identify the five clinically most consequential CYP450 inhibitor and inducer pairs and state the direction and magnitude of the interaction.

  • Explain how protein binding, tissue distribution and enterohepatic recycling change the interpretation of a serum drug concentration.

Your checkpoint

A 15-item pharmacokinetic calculation worksheet with full working shown, all items correct on the second attempt, plus a one-page CYP450 interaction table with mechanisms.

Week 3

Pharmaceutical sciences (pharmaceutics, pharmacology, medicinal chemistry, pharmacokinetics) & Pharmaceutical calculations, compounding and product preparation

  • Match eight modified-release or specialty dosage forms to their release mechanism, and state one administration or food caution for each.

  • Apply acid-base and partition principles: for five drugs, identify the ionisable functional group, estimate the predominant species at physiological pH, and predict the effect on absorption and renal reabsorption.

  • Solve 30 compounding and calculation problems covering percentage strength, ratio strength, alligation, dilution, aliquot weighing, and milliequivalent conversion to within 2% of the correct answer.

  • Compute paediatric doses by weight and body surface area and verify each against an adult maximum before accepting the result.

  • Convert between infusion rates, concentrations and drop rates, and set up a two-step check for any high-risk calculation.

Your checkpoint

A timed 25-question calculation set completed at 85% or better, accompanied by a tally of error types (unit conversion, decimal placement, formula selection) and the corrective rule for each.

Week 4

Pharmacy practice and pharmacotherapy (assessment, therapeutic decision-making, monitoring)

  • Construct a first-line, alternative and contraindication grid for ten high-frequency conditions encompassing hypertension, type 2 diabetes, heart failure, asthma/COPD, atrial fibrillation, uncomplicated UTI, community-acquired pneumonia, depression, hypothyroidism and GERD.

  • Apply a four-part monitoring framework (efficacy, toxicity, adherence, laboratory parameters) to five written patient cases and specify the follow-up interval for each.

  • Adjust doses for renal impairment, hepatic impairment and frailty for ten commonly used drugs, naming the parameter that drives each adjustment.

  • Recognise referral red flags in eight common presentations, including chest pain descriptors, neurological deficit, GI bleeding and acute vision change.

  • Justify each therapeutic choice in two paragraphs using guideline logic rather than memorised brand names.

Your checkpoint

A completed condition-to-drug-to-monitoring grid plus 20 case vignettes answered with a two-sentence written rationale each, scored at 80% or better.

Week 5

Pharmacy practice and pharmacotherapy (assessment, therapeutic decision-making, monitoring) & Drug distribution, dispensing and medication safety/quality assurance

  • Sequence treatment escalation for three chronic diseases, stating the titration interval, the add-on rationale and the point at which the regimen should be abandoned.

  • Audit ten simulated prescriptions for indication, dose, duplication, interaction, allergy and formulation appropriateness, and document the intervention you would make for each defect found.

  • Apply high-alert medication safeguards to anticoagulants, insulin, opioids and concentrated electrolytes, and distinguish at least ten look-alike/sound-alike name pairs with the mitigation for each.

  • Walk through the dispensing workflow end to end for two prescriptions, catching every seeded error before release.

  • Explain how error-reporting systems, root-cause analysis and just-culture principles convert a near miss into a system fix.

Your checkpoint

A prescription audit file of ten orders with documented interventions achieving a 90% or better error-detection rate, including two correctly identified look-alike/sound-alike traps.

Week 6

Professional practice, law, ethics and regulatory requirements & Social, behavioural and administrative pharmacy sciences

  • Outline the Canadian drug-approval and scheduling pathway from notice of compliance to drug identification number, and state the pharmacist's legal record-keeping duty at each stage.

  • Separate federal from provincial or territorial jurisdiction over scheduling, prescribing authority, dispensing records and privacy, and list the three most commonly tested boundaries.

  • Apply a four-step ethical framework to five scenarios covering conflict of interest, conscientious objection, privacy breach, an impaired colleague and disclosure of a dispensing error.

  • Describe the administrative levers that shape pharmacy practice, including formulary placement, third-party reimbursement, inventory control and staffing models, and explain how each affects patient access.

  • Explain how social and behavioural factors such as health literacy, cost and cultural background change whether a patient fills and continues a prescription.

Your checkpoint

Written answers to five ethics scenarios, each citing the governing legal rule and the ethical principle relied on, plus a one-page federal-versus-provincial jurisdiction comparison.

Week 7

Communication, education and interprofessional collaboration & Health promotion, population health and public health

  • Structure a counselling session using plain language, a limited key-message set and teach-back for six high-risk drugs: warfarin, insulin, inhaled corticosteroids, methotrexate, opioids and a direct oral anticoagulant.

  • Draft an SBAR communication for three interprofessional scenarios and identify the decision you are asking the prescriber to make in each.

  • Write a ten-turn motivational interviewing dialogue that demonstrates open questions, affirmation, reflection and summarising, and label where change talk appears.

  • Explain the pharmacist's role in immunisation, screening, harm reduction and chronic-disease prevention, and state which interventions have the strongest population-level evidence.

  • Apply social determinants of health to two case patients and propose one pharmacy-level intervention for each that is feasible in a community setting.

Your checkpoint

Three counselling scripts scored against a ten-point teach-back checklist, plus one complete SBAR note and one annotated motivational interviewing transcript.

Week 8

Evidence-based practice, research methods and informatics

  • Appraise one randomised trial and one meta-analysis against validity criteria: randomisation, allocation concealment, blinding, intention-to-treat, effect size, confidence interval and applicability to your patient.

  • Calculate number needed to treat, sensitivity, specificity, positive and negative predictive value, and absolute risk reduction from a supplied two-by-two table, and interpret a forest plot.

  • Describe the informatics backbone of practice, including computerised order entry with clinical decision support, e-prescribing, interoperability standards and privacy obligations.

  • Sit two full-length timed mock examinations under exam conditions and categorise every error by domain, knowledge gap versus misreading versus calculation slip.

  • Convert your error categories into a one-page top-20 weak-point sheet and schedule a spaced re-test of each item for the final week.

Your checkpoint

Two completed timed mock examinations with a categorised error log and a one-page weak-point revision sheet in which every entry carries a specific re-test date.

Milestones

Week 2: Reproduce the autonomic receptor table and three pharmacokinetic formulas from a blank page with 90% accuracy, and confirm that all week 1 error-log entries have been re-tested.

Week 4: Score 75% or better on a 60-question mixed set drawn from the biomedical, pharmaceutical and calculation domains, and show that every miss is traced to a named knowledge gap rather than left as 'review later'.

Week 6: Achieve 80% or better on a 40-question set covering pharmacotherapy, dispensing safety, law and ethics, and confirm the calculation error tally from week 3 has not recurred.

Week 8: Complete both full-length timed mocks within the time limit, demonstrate a rising trend across the two scores, and show the weak-point sheet is closed out or explicitly deferred with a scheduled re-test.